United States Over-The-Counter (OTC) Drugs Market Report 2018

United States Over-The-Counter (OTC) Drugs Market Report 2018

1 Over-The-Counter (OTC) Drugs Overview

1.1 Product Overview and Scope of Over-The-Counter (OTC) Drugs

1.2 Classification of Over-The-Counter (OTC) Drugs by Product Category

1.2.1 United States Over-The-Counter (OTC) Drugs Market Size (Sales Volume) Comparison by Type (2013-2025)

1.2.2 United States Over-The-Counter (OTC) Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2017

1.2.3 Cold and Flu Products

1.2.4 Analgesics

1.2.5 Dermatological Products

1.2.6 Gastrointestinal Products

1.2.7 Vitamin

1.2.8 Other

1.3 United States Over-The-Counter (OTC) Drugs Market by Application/End Users

1.3.1 United States Over-The-Counter (OTC) Drugs Market Size (Consumption) and Market Share Comparison by Application (2013-2025)

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.4 United States Over-The-Counter (OTC) Drugs Market by Region

1.4.1 United States Over-The-Counter (OTC) Drugs Market Size (Value) Comparison by Region (2013-2025)

1.4.2 The West Over-The-Counter (OTC) Drugs Status and Prospect (2013-2025)

1.4.3 Southwest Over-The-Counter (OTC) Drugs Status and Prospect (2013-2025)

1.4.4 The Middle Atlantic Over-The-Counter (OTC) Drugs Status and Prospect (2013-2025)

1.4.5 New England Over-The-Counter (OTC) Drugs Status and Prospect (2013-2025)

1.4.6 The South Over-The-Counter (OTC) Drugs Status and Prospect (2013-2025)

1.4.7 The Midwest Over-The-Counter (OTC) Drugs Status and Prospect (2013-2025)

1.5 United States Market Size (Value and Volume) of Over-The-Counter (OTC) Drugs (2013-2025)

1.5.1 United States Over-The-Counter (OTC) Drugs Sales and Growth Rate (2013-2025)

1.5.2 United States Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2013-2025)

2 United States Over-The-Counter (OTC) Drugs Market Competition by Players/Suppliers

2.1 United States Over-The-Counter (OTC) Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)

2.2 United States Over-The-Counter (OTC) Drugs Revenue and Share by Players/Suppliers (2013-2018)

2.3 United States Over-The-Counter (OTC) Drugs Average Price by Players/Suppliers (2013-2018)

2.4 United States Over-The-Counter (OTC) Drugs Market Competitive Situation and Trends

2.4.1 United States Over-The-Counter (OTC) Drugs Market Concentration Rate

2.4.2 United States Over-The-Counter (OTC) Drugs Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Over-The-Counter (OTC) Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Over-The-Counter (OTC) Drugs Sales (Volume) and Revenue (Value) by Region (2013-2018)

3.1 United States Over-The-Counter (OTC) Drugs Sales and Market Share by Region (2013-2018)

3.2 United States Over-The-Counter (OTC) Drugs Revenue and Market Share by Region (2013-2018)

3.3 United States Over-The-Counter (OTC) Drugs Price by Region (2013-2018)

4 United States Over-The-Counter (OTC) Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)

4.1 United States Over-The-Counter (OTC) Drugs Sales and Market Share by Type (Product Category) (2013-2018)

4.2 United States Over-The-Counter (OTC) Drugs Revenue and Market Share by Type (2013-2018)

4.3 United States Over-The-Counter (OTC) Drugs Price by Type (2013-2018)

4.4 United States Over-The-Counter (OTC) Drugs Sales Growth Rate by Type (2013-2018)

5 United States Over-The-Counter (OTC) Drugs Sales (Volume) by Application (2013-2018)

5.1 United States Over-The-Counter (OTC) Drugs Sales and Market Share by Application (2013-2018)

5.2 United States Over-The-Counter (OTC) Drugs Sales Growth Rate by Application (2013-2018)

5.3 Market Drivers and Opportunities

6 United States Over-The-Counter (OTC) Drugs Players/Suppliers Profiles and Sales Data

6.1 Bayer

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Over-The-Counter (OTC) Drugs Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Bayer Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.1.4 Main Business/Business Overview

6.2 Boehringer Ingelheim

6.2.2 Over-The-Counter (OTC) Drugs Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.2.4 Main Business/Business Overview

6.3 GSK

6.3.2 Over-The-Counter (OTC) Drugs Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 GSK Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.3.4 Main Business/Business Overview

6.4 Novartis

6.4.2 Over-The-Counter (OTC) Drugs Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Novartis Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.4.4 Main Business/Business Overview

6.5 Pfizer

6.5.2 Over-The-Counter (OTC) Drugs Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Pfizer Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.5.4 Main Business/Business Overview

6.6 PGT healthcare

6.6.2 Over-The-Counter (OTC) Drugs Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 PGT healthcare Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.6.4 Main Business/Business Overview

6.7 Sanofi

6.7.2 Over-The-Counter (OTC) Drugs Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Sanofi Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.7.4 Main Business/Business Overview

6.8 Teva Pharmaceuticals

6.8.2 Over-The-Counter (OTC) Drugs Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.8.4 Main Business/Business Overview

6.9 Takeda

6.9.2 Over-The-Counter (OTC) Drugs Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Takeda Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.9.4 Main Business/Business Overview

6.10 Cipla

6.10.2 Over-The-Counter (OTC) Drugs Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Cipla Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

6.10.4 Main Business/Business Overview

6.11 Sun Pharmaceutical Industries

6.12 Glenmark

6.13 Innovus Pharmaceuticals

7 Over-The-Counter (OTC) Drugs Manufacturing Cost Analysis

7.1 Over-The-Counter (OTC) Drugs Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Over-The-Counter (OTC) Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Over-The-Counter (OTC) Drugs Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Over-The-Counter (OTC) Drugs Major Manufacturers in 2017

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Over-The-Counter (OTC) Drugs Market Size (Value and Volume) Forecast (2018-2025)

11.1 United States Over-The-Counter (OTC) Drugs Sales Volume, Revenue Forecast (2018-2025)

11.2 United States Over-The-Counter (OTC) Drugs Sales Volume Forecast by Type (2018-2025)

11.3 United States Over-The-Counter (OTC) Drugs Sales Volume Forecast by Application (2018-2025)

11.4 United States Over-The-Counter (OTC) Drugs Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Over-The-Counter (OTC) Drugs

Figure United States Over-The-Counter (OTC) Drugs Market Size (K Units) by Type (2013-2025)

Figure United States Over-The-Counter (OTC) Drugs Sales Volume Market Share by Type (Product Category) in 2017

Figure Cold and Flu Products Product Picture

Figure Analgesics Product Picture

Figure Dermatological Products Product Picture

Figure Gastrointestinal Products Product Picture

Figure Vitamin Product Picture

Figure Other Product Picture

Figure United States Over-The-Counter (OTC) Drugs Market Size (K Units) by Application (2013-2025)

Figure United States Sales Market Share of Over-The-Counter (OTC) Drugs by Application in 2017

Figure Hospital Pharmacy Examples

Table Key Downstream Customer in Hospital Pharmacy

Figure Retail Pharmacy Examples

Table Key Downstream Customer in Retail Pharmacy

Figure Online Pharmacy Examples

Table Key Downstream Customer in Online Pharmacy

Figure United States Over-The-Counter (OTC) Drugs Market Size (Million USD) by Region (2013-2025)

Figure The West Over-The-Counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure Southwest Over-The-Counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure The Middle Atlantic Over-The-Counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure New England Over-The-Counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure The South of US Over-The-Counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure The Midwest Over-The-Counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure United States Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2013-2025)

Figure United States Over-The-Counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure United States Over-The-Counter (OTC) Drugs Market Major Players Product Sales Volume (K Units) (2013-2018)

Table United States Over-The-Counter (OTC) Drugs Sales (K Units) of Key Players/Suppliers (2013-2018)

Table United States Over-The-Counter (OTC) Drugs Sales Share by Players/Suppliers (2013-2018)

Figure 2017 United States Over-The-Counter (OTC) Drugs Sales Share by Players/Suppliers

Figure 2017 United States Over-The-Counter (OTC) Drugs Sales Share by Players/Suppliers

Figure United States Over-The-Counter (OTC) Drugs Market Major Players Product Revenue (Million USD) (2013-2018)

Table United States Over-The-Counter (OTC) Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)

Table United States Over-The-Counter (OTC) Drugs Revenue Share by Players/Suppliers (2013-2018)

Figure 2017 United States Over-The-Counter (OTC) Drugs Revenue Share by Players/Suppliers

Figure 2017 United States Over-The-Counter (OTC) Drugs Revenue Share by Players/Suppliers

Table United States Market Over-The-Counter (OTC) Drugs Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)

Figure United States Market Over-The-Counter (OTC) Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2017

Figure United States Over-The-Counter (OTC) Drugs Market Share of Top 3 Players/Suppliers

Figure United States Over-The-Counter (OTC) Drugs Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Over-The-Counter (OTC) Drugs Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Over-The-Counter (OTC) Drugs Product Category

Table United States Over-The-Counter (OTC) Drugs Sales (K Units) by Region (2013-2018)

Table United States Over-The-Counter (OTC) Drugs Sales Share by Region (2013-2018)

Figure United States Over-The-Counter (OTC) Drugs Sales Share by Region (2013-2018)

Figure United States Over-The-Counter (OTC) Drugs Sales Market Share by Region in 2017

Table United States Over-The-Counter (OTC) Drugs Revenue (Million USD) and Market Share by Region (2013-2018)

Table United States Over-The-Counter (OTC) Drugs Revenue Share by Region (2013-2018)

Figure United States Over-The-Counter (OTC) Drugs Revenue Market Share by Region (2013-2018)

Figure United States Over-The-Counter (OTC) Drugs Revenue Market Share by Region in 2017

Table United States Over-The-Counter (OTC) Drugs Price (USD/Unit) by Region (2013-2018)

Table United States Over-The-Counter (OTC) Drugs Sales (K Units) by Type (2013-2018)

Table United States Over-The-Counter (OTC) Drugs Sales Share by Type (2013-2018)

Figure United States Over-The-Counter (OTC) Drugs Sales Share by Type (2013-2018)

Figure United States Over-The-Counter (OTC) Drugs Sales Market Share by Type in 2017

Table United States Over-The-Counter (OTC) Drugs Revenue (Million USD) and Market Share by Type (2013-2018)

Table United States Over-The-Counter (OTC) Drugs Revenue Share by Type (2013-2018)

Figure Revenue Market Share of Over-The-Counter (OTC) Drugs by Type (2013-2018)

Figure Revenue Market Share of Over-The-Counter (OTC) Drugs by Type in 2017

Table United States Over-The-Counter (OTC) Drugs Price (USD/Unit) by Types (2013-2018)

Figure United States Over-The-Counter (OTC) Drugs Sales Growth Rate by Type (2013-2018)

Table United States Over-The-Counter (OTC) Drugs Sales (K Units) by Application (2013-2018)

Table United States Over-The-Counter (OTC) Drugs Sales Market Share by Application (2013-2018)

Figure United States Over-The-Counter (OTC) Drugs Sales Market Share by Application (2013-2018)

Figure United States Over-The-Counter (OTC) Drugs Sales Market Share by Application in 2017

Table United States Over-The-Counter (OTC) Drugs Sales Growth Rate by Application (2013-2018)

Figure United States Over-The-Counter (OTC) Drugs Sales Growth Rate by Application (2013-2018)

Table Bayer Basic Information List

Table Bayer Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Bayer Over-The-Counter (OTC) Drugs Sales Growth Rate (2013-2018)

Figure Bayer Over-The-Counter (OTC) Drugs Sales Market Share in United States (2013-2018)

Figure Bayer Over-The-Counter (OTC) Drugs Revenue Market Share in United States (2013-2018)

Table Boehringer Ingelheim Basic Information List

Table Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales Growth Rate (2013-2018)

Figure Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales Market Share in United States (2013-2018)

Figure Boehringer Ingelheim Over-The-Counter (OTC) Drugs Revenue Market Share in United States (2013-2018)

Table GSK Basic Information List

Table GSK Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure GSK Over-The-Counter (OTC) Drugs Sales Growth Rate (2013-2018)

Figure GSK Over-The-Counter (OTC) Drugs Sales Market Share in United States (2013-2018)

Figure GSK Over-The-Counter (OTC) Drugs Revenue Market Share in United States (2013-2018)

Table Novartis Basic Information List

Table Novartis Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Novartis Over-The-Counter (OTC) Drugs Sales Growth Rate (2013-2018)

Figure Novartis Over-The-Counter (OTC) Drugs Sales Market Share in United States (2013-2018)

Figure Novartis Over-The-Counter (OTC) Drugs Revenue Market Share in United States (2013-2018)

Table Pfizer Basic Information List

Table Pfizer Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Pfizer Over-The-Counter (OTC) Drugs Sales Growth Rate (2013-2018)

Figure Pfizer Over-The-Counter (OTC) Drugs Sales Market Share in United States (2013-2018)

Figure Pfizer Over-The-Counter (OTC) Drugs Revenue Market Share in United States (2013-2018)

Table PGT healthcare Basic Information List

Table PGT healthcare Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure PGT healthcare Over-The-Counter (OTC) Drugs Sales Growth Rate (2013-2018)

Figure PGT healthcare Over-The-Counter (OTC) Drugs Sales Market Share in United States (2013-2018)

Figure PGT healthcare Over-The-Counter (OTC) Drugs Revenue Market Share in United States (2013-2018)

Table Sanofi Basic Information List

Table Sanofi Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Sanofi Over-The-Counter (OTC) Drugs Sales Growth Rate (2013-2018)

Figure Sanofi Over-The-Counter (OTC) Drugs Sales Market Share in United States (2013-2018)

Figure Sanofi Over-The-Counter (OTC) Drugs Revenue Market Share in United States (2013-2018)

Table Teva Pharmaceuticals Basic Information List

Table Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales Growth Rate (2013-2018)

Figure Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales Market Share in United States (2013-2018)

Figure Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Revenue Market Share in United States (2013-2018)

Table Takeda Basic Information List

Table Takeda Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Takeda Over-The-Counter (OTC) Drugs Sales Growth Rate (2013-2018)

Figure Takeda Over-The-Counter (OTC) Drugs Sales Market Share in United States (2013-2018)

Figure Takeda Over-The-Counter (OTC) Drugs Revenue Market Share in United States (2013-2018)

Table Cipla Basic Information List

Table Cipla Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Cipla Over-The-Counter (OTC) Drugs Sales Growth Rate (2013-2018)

Figure Cipla Over-The-Counter (OTC) Drugs Sales Market Share in United States (2013-2018)

Figure Cipla Over-The-Counter (OTC) Drugs Revenue Market Share in United States (2013-2018)

Table Sun Pharmaceutical Industries Basic Information List

Table Glenmark Basic Information List

Table Innovus Pharmaceuticals Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Over-The-Counter (OTC) Drugs

Figure Manufacturing Process Analysis of Over-The-Counter (OTC) Drugs

Figure Over-The-Counter (OTC) Drugs Industrial Chain Analysis

Table Raw Materials Sources of Over-The-Counter (OTC) Drugs Major Players/Suppliers in 2017

Table Major Buyers of Over-The-Counter (OTC) Drugs

Table Distributors/Traders List

Figure United States Over-The-Counter (OTC) Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)

Figure United States Over-The-Counter (OTC) Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure United States Over-The-Counter (OTC) Drugs Price (USD/Unit) Trend Forecast (2018-2025)

Table United States Over-The-Counter (OTC) Drugs Sales Volume (K Units) Forecast by Type (2018-2025)

Figure United States Over-The-Counter (OTC) Drugs Sales Volume (K Units) Forecast by Type (2018-2025)

Figure United States Over-The-Counter (OTC) Drugs Sales Volume (K Units) Forecast by Type in 2025

Table United States Over-The-Counter (OTC) Drugs Sales Volume (K Units) Forecast by Application (2018-2025)

Figure United States Over-The-Counter (OTC) Drugs Sales Volume (K Units) Forecast by Application (2018-2025)

Figure United States Over-The-Counter (OTC) Drugs Sales Volume (K Units) Forecast by Application in 2025

Table United States Over-The-Counter (OTC) Drugs Sales Volume (K Units) Forecast by Region (2018-2025)

Table United States Over-The-Counter (OTC) Drugs Sales Volume Share Forecast by Region (2018-2025)

Figure United States Over-The-Counter (OTC) Drugs Sales Volume Share Forecast by Region (2018-2025)

Figure United States Over-The-Counter (OTC) Drugs Sales Volume Share Forecast by Region in 2025

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources